Transgenic plants as edible vaccines — reality and future prospects

This review describes the recent progress in the construction of transgenic plants for vaccine production Transgenic plants are an attractive and cost-effective alternative to microbial systems for the production of proteins with pharmaceutical value. Advances in biotechnology are enabling plants to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Datum:1999
1. Verfasser: Domansky, N.N.
Format: Artikel
Sprache:English
Veröffentlicht: Інститут молекулярної біології і генетики НАН України 1999
Schriftenreihe:Биополимеры и клетка
Schlagworte:
Online Zugang:http://dspace.nbuv.gov.ua/handle/123456789/155869
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Zitieren:Transgenic plants as edible vaccines — reality and future prospects / N.N. Domansky // Биополимеры и клетка. — 1999. — Т. 15, № 1. — С. 5-9. — Бібліогр.: 15 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine
Beschreibung
Zusammenfassung:This review describes the recent progress in the construction of transgenic plants for vaccine production Transgenic plants are an attractive and cost-effective alternative to microbial systems for the production of proteins with pharmaceutical value. Advances in biotechnology are enabling plants to be exploited the expression of candidate vaccine antigens with the goal of using the edible plant organs for economical delivery of oral vaccines. It has recently been shown that genes encoding antigens of bacterial and viral pathogens can be expressed in plants in a form in which they retain native immunogenic properties. Transgenic potato tubers expressing bacterial antigens stimulated humoral and mucosal immune response; when they were provided as a food. Although the utility of «edible vaccines» to prevent disease remains to be established, the successful implementation of this strategy can be the first step on the way to modern vaccines of new generation.